Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation.
Byeon HK, Na HJ, Yang YJ, Ko S, Yoon SO, Ku M, Yang J, Kim JW, Ban MJ, Kim JH, Kim DH, Kim JM, Choi EC, Kim CH, Yoon JH, Koh YW.
Byeon HK, et al. Among authors: kim jm, kim dh, kim ch, kim jw, kim jh.
Oncotarget. 2017 Jan 3;8(1):596-609. doi: 10.18632/oncotarget.13480.
Oncotarget. 2017.
PMID: 27880942
Free PMC article.